Satomi Shibazaki

Adiponectin as a Biomarker of the Metabolic Syndrome

Miwa Ryo, Tadashi Nakamura, Shinji Kihara et al. · Circulation Journal · 2004 · 764 citations · Full text

Medicine, Biochemistry, Endocrinology +17

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

[Development of index of social activities for the elderly].

Shuji Hashimoto, R Aoki, Akiko Tamakoshi et al. · PubMed · 1997 · 26 citations

Education, Psychology, Geriatric Assessment +15

A Higher Proinsulin Response to Glucose Loading Predicts Deteriorating Fasting Plasma Glucose and Worsening to Diabetes in Subjects with Impaired Glucose Tolerance

Ikuo Inoue, Keiichi Takahashi, Shigehiro Katayama et al. · Diabetic Medicine · 1996 · 25 citations

Medicine, Endocrinology, Diabetology +16